Johnson & Johnson to acquire Scios Inc. for 50.74 times revenue

From: Weekly Corporate Growth Report | Date: February 17, 2003| Author: Anonymous | Copyright information

Featured Transaction

The Deal: Johnson & Johnson (J&J) has agreed to acquire Scios Inc. in a deal valued at $2.4 billion dollars. The transaction still requires approval from Scios shareholders and federal regulatory agencies. The deal is expected to close in the second quarter of 2003.

Discussion: Scios develops pharmaceutical treatments primarily targeting heart conditions and inflammatory diseases. The company's leading product, Natrecor, is an intravenous genetical...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

RHEUMATOID ARTHRITIS DRUG MARKET HEATS UP 3 FIRMS SCRAMBLE TO GRAB NO. 1 SPOT
The Boston Globe ; The fight over the lucrative market for rheumatoid arthritis drugs is heating up. In the last five years, three similar drugs have been introduced that offer patients the promise of getting back on their feet. Now the manufacturers of all three are jockeying for market share so they can be the
Rheumatoid arthritis drug market heats up.
Knight Ridder/Tribune Business News ; By Christopher Rowland, The Boston Globe Knight Ridder/Tribune Business News Oct. 14--The fight over the lucrative market for rheumatoid arthritis drugs is heating up. In the last five years, three similar ...
Abbott drug Humira best in early stages Newer rheumatoid arthritis patients do best, results show
Chicago Sun-Times ; Abbott Laboratories' new rheumatoid arthritis drug, Humira, on track to ring up $250 million in global sales this year, is most effective in treating early stages of the disease, according to clinical trial results released by the company Thursday. North Chicago-based Abbott said the drug, which is
New drugs slow progression of rheumatoid arthritis.
Chicago Tribune (Chicago, IL) ; Byline: Bruce Japsen CHICAGO _ Two years ago the pain of the Rev. John Madden's rheumatoid arthritis became so intense he could barely pick up the chalice to distribute communion to his parishioners each Sunday. Then he began taking Humira, Abbott Laboratories' experimental drug. Humira, said
MANAGEMENT OF RHEUMATOID ARTHRITIS.(TRIAD)
The News & Record (Piedmont Triad, NC) ; Byline: Robert M. Gay< Special to the News & Record Rheumatoid arthritis (RA) is a relatively common disease in which the lining or membranes of joints become inflamed ...